Search

everythinglearnresearchcommunity

for

Search:↓

The editorial concludes that the field of hair loss treatment has become more scientific and that effective treatments are important for self-esteem and job prospects.

Most hair loss in kids and teens is due to common conditions, and hair usually grows back within 6 months.

A woman's hair loss was due to trichotillomania, which is often misdiagnosed and can require different treatments based on age and underlying conditions.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

A girl with rickets and hair loss was found to have a rare condition where her body didn't respond to vitamin D treatment.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Some breast cancer chemotherapy can cause permanent hair loss.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.